Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: Jack of All Trades who wrote (20739)	5/22/1998 10:56:00 AM
From: Due Diligence	Respond to of 34592

BLHG: Mentioned in release,today. Jimbo (COMTEX) Medical Breakthrough Announcements Continue; Anticort Treatm Medical Breakthrough Announcements Continue; Anticort Treatment for AIDS HOLLYWOOD, CALIF. (May 22) BUSINESS WIRE -May 22, 1998--Emerging Company Report, the nationally syndicated television program that profiles emerging-growth companies (http://www.emergingcompany.com), features an interview with Dr. Alfred Sapse, chief executive officer of Steroidogenesis Inhibitors International (OTC/BB:STGI) and the developer of the Anticort drug. Recent announcements of possible cancer breakthroughs have brought attention to companies like Genentech (NYSE:GNE), Entremed (Nasdaq:ENMD) and Abbott Labs (NYSE:ABT). Anticort is an anti-cortisol (i.e., steroidogenesis inhibitor) drug that prevents and treats the deadly immunosuppressive effects of elevated cortisol. When Sapse first began to evaluate Anticort's therapeutic potential, AIDS and Alzheimer's presented themselves as the two diseases most likely to be responsive. Due to the rapid spread of AIDS, and the immense suffering associated with the fatal disease, Sapse decided to initially focus on HIV-positive patients. A preliminary study of 60 HIV-positive patients in Brazil found Anticort to be effective in increasing CD4 (immune cell) counts and drastically reducing mortality. After submitting a comprehensive clinical program, STGI has received Food and Drug Administration approval (IND 52,663) to begin clinically testing Anticort on HIV-positive patients under a Phase IB/IIA setting. Also being interviewed on this week's program is Richard Verdiramo, director of marketing with Beacon Light Holding Corp. (OTC/BB:BLHG). Beacon Light Holding has entered into a joint venture agreement with Pinnacle International Inc. and the XIN HUI Orient Light Industries Inc., to produce a variety of plastic products in China's Guangdong Province. With a population in excess of 65 million people, Guangdong Province enjoys a free enterprise system very similar to that of the Western Hemisphere. The factory previously only produced writing pens with production capacity of 400 million units per year, translating to more than $60 million in sales. However, the plastic injection molds can be adapted to produce a variety of plastic products that allows for flexibility and diversification in product line. Other companies discussed on this week's program include: Advanced Engine Technologies Inc. (OTC/BB:AENG), a Colorado company that owns the U.S. rights to promote and market a revolutionary new internal combustion engine, known as the OX-2. The company Thursday announced a joint venture agreement with Carroll Shelby, legendary automotive designer, famous for the Shelby Ford (NYSE:F) Mustang, to develop the OX-2 engine for use in hybrid electric vehicles. Shelby granted an exclusive interview to Emerging Company Report to discuss the venture. HomeCom Communications Inc. (Nasdaq:HCOM) is an Internet-based Web design and hosting company whose clients include the CIA and Time Warner (NYSE:TWX). Touted as one of the top 20 Internet companies, HomeCom joins companies like America Online (NYSE:AOL) and Excite (Nasdaq:XCIT), making news on Wall Street lately. Emerging Company Report is seen Friday evenings at 11 p.m. ET, 8 p.m. PT, and again on Sunday morning at 11:30 a.m. ET, 8:30 a.m. PT on 140 cable TV systems nationwide. The program is also broadcast "On-Demand" at its Web site, emergingcompany.com. -0- MT/la* TJM/la CONTACT: Emerging Company Report Donald A. Baillargeon, 805/336-0507 emergingcompany.com KEYWORD: CALIFORNIA COLORADO INDUSTRY KEYWORD: PHARMACEUTICAL AUTOMOTIVE CHEMICALS/PLASTICS COMPUTERS/ELECTRONICS COMED INTERACTIVE/MULTIMEDIA/INTERNET Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com * end of story *